Portfoliotracker

Lavipharm S.A.

LAVI.AT · ATHENS · Healthcare Drug Manufacturers - Specialty & Generic 50/100 C

1,496 €
▲ +0,010 (+0,67 %)
Trading delayed by 15 min
Price as of 17. 11. 13:14, fetched 17. 11. 13:34
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score50 / 100 Market cap256 mil. € P/E42,9 Forward P/E– P/S4,1 P/B4,5 EV/EBITDA19,4 Dividend yield1,35 % FCF yield0,80 % EPS0,03 € Net margin8,2 % Return on equity10,2 % Beta1,30 Debt / equity0,73
52-week range 0,80 to 1,74
3-month average volume0,1 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Lavipharm S.A. engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, cosmetics, and healthcare products to physicians and pharmacists in Greece and internationally. The company offers pharmaceutical products for cardiology, oncology-urology, central nervous system, chronic pain, and self- treatment. It also provides prescription medicines and over the counter (OTC) products, as well as LIFELAB CBD products. The company was founded in 1911 and is based in Paiania, Greece.

Employees
306
Country
Greece
Data since
8. 11. 1995

Explore further

Similar companies BYLOT.ATELHA.ATPPC.ATELPE.ATGEKTERNA.AT

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account